| Literature DB >> 25432940 |
Nathan V Whelan1, Kevin M Kocot2, Scott R Santos3, Kenneth M Halanych1.
Abstract
Nemerteans are one of few animal groups that have evolved the ability to utilize toxins for both defense and subduing prey, but little is known about specific nemertean toxins. In particular, no study has identified specific toxin genes even though peptide toxins are known from some nemertean species. Information about toxin genes is needed to better understand evolution of toxins across animals and possibly provide novel targets for pharmaceutical and industrial applications. We sequenced and annotated transcriptomes of two free-living and one commensal nemertean and annotated an additional six publicly available nemertean transcriptomes to identify putative toxin genes. Approximately 63-74% of predicted open reading frames in each transcriptome were annotated with gene names, and all species had similar percentages of transcripts annotated with each higher-level GO term. Every nemertean analyzed possessed genes with high sequence similarities to known animal toxins including those from stonefish, cephalopods, and sea anemones. One toxin-like gene found in all nemerteans analyzed had high sequence similarity to Plancitoxin-1, a DNase II hepatotoxin that may function well at low pH, which suggests that the acidic body walls of some nemerteans could work to enhance the efficacy of protein toxins. The highest number of toxin-like genes found in any one species was seven and the lowest was three. The diversity of toxin-like nemertean genes found here is greater than previously documented, and these animals are likely an ideal system for exploring toxin evolution and industrial applications of toxins.Entities:
Keywords: Nemertea; cytotoxin; hepatotoxin; ribbon worm; toxin; transcriptome
Mesh:
Substances:
Year: 2014 PMID: 25432940 PMCID: PMC4986456 DOI: 10.1093/gbe/evu258
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
Assembly Statistics
| Species | GenBank Number | Sequencing Platform | Raw reads | N50 | GC% | Mean Contig Length | Number of Contigs | Longest contig | % Partial CEGMA Genes | % Complete CEGMA Genes |
|---|---|---|---|---|---|---|---|---|---|---|
| SRX731465 | HiSeq 2x100 | 83,045,507 | 1720 | 43.8 | 1047.06 | 109,120 | 15,014 | 99.19 | 93.55 | |
| SRX731466 | HiSeq 2x100 | 86,271,698 | 1493 | 45.6 | 869.65 | 99,203 | 25,470 | 93.95 | 86.69 | |
| SRX732127 | HiSeq 2x100 | 39,262,732 | 1492 | 39.3 | 916.39 | 79,313 | 13,710 | 98.79 | 88.31 | |
| SRX205320 | Genome Analyzer II 2x100 | 26,112,259 | 471 | 36.9 | 431.00 | 122,233 | 4,383 | 65.32 | 16.53 | |
| SRX524866–SRX534868 | Genome Analyzer IIx 2x75 | 12,062,451 | 1241 | 37.4 | 738.21 | 67,317 | 14,570 | 97.58 | 86.69 | |
| SRX205323 | Genome Analyzer II 2x100 | 26,688,280 | 515 | 41.6 | 458.84 | 194,257 | 8,534 | 83.47 | 28.23 | |
| SRX565176–SRX565181 | HiSeq 1x100 | 95,576,010 | 2292 | 43.0 | 1186.57 | 79,452 | 25,184 | 98.79 | 93.55 | |
| SRXX565182–SRX565183 | HiSeq 1x100 | 59,763,351 | 2105 | 43.6 | 1082.25 | 156,014 | 26,007 | 98.39 | 92.74 | |
| SRX565174, SRX565175 | HiSeq 1x100 | 25,452,210 | 3246 | 43.1 | 1539.37 | 96,066 | 23,116 | 98.79 | 91.94 |
Annotation Statistics
| Species | Number (%) of transcripts annotated with BLASTn | Number (%) of transcripts with predicted ORF | Number (%) of ORFs annotated with BLASTp |
|---|---|---|---|
| 33,964 (41.8) | 40,421 (37.0) | 30,072 (74.4) | |
| 36,452 (35.7) | 40,530 (40.9) | 28,460 (70.2) | |
| 38,364 (34.3) | 51,660 (46.2) | 33,904 (65.6) | |
| 39,525 (32.2) | 37,688 (30.7) | 24,329 (64.5) | |
| 22,328 (32.9) | 25,652 (37.8) | 18,391 (71.7) | |
| 32,011 (16.4) | 35,451 (18.2) | 22,357 (63.1) | |
| 29,048 (35.4) | 35,714 (47.8) | 24,852 (70.0) | |
| 39,770 (24.6) | 47,288 (47.2) | 33,468 (70.8) | |
| 38,771 (38.7) | 52,422 (32.4) | 33,809 (64.5) |
FA–G Pie charts with percentages of the higher-level GO terms for each species except Cep. hongkongeinsis and C. marginatus (see Riesgo et al. 2012). (A) M. grossa, (B) Para. peregrine, (C) T. polymorphus, (D) Cep. linearis, (E) L. longissimus, (F) L. ruber, (G) R. lacteus. (H) Bar chart of genes annotated with select “Biological Process” lower-level GO terms. (I) Bar chart of genes annotated with select “Cellular Component” and “Molecular Function” lower-level GO terms. Bar plot colors are referenced in (H).
Toxin Genes Identified in Each Species
| Species | Identifier | Trinotate Swiss-Prot annotation | Functional annotation and PFAM domains | Putative orthologs |
|---|---|---|---|---|
| M1 | A0ZSK4: Neoverrucotoxin subunit beta | SNTX/VTX toxin; hemolytic activity | P1, Ch2, Cl1, Cm1, Llo1, Lr8 | |
| M2 | Q3SB03: Cysteine-rich venom protein pseudechetoxin-like | CAP domain; ShK domains; Potassium channel blocker | P2, Cl2 | |
| M3 | Q75WF2: Plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | P4, T2, Ch3, Cl3, Cm2, Llo2, Lr2, Rl2 | |
| P1 | A0ZSK3: Neoverrucotoxin subunit alpha | SNTX/VTX toxin; hemolytic activity | M1, Ch2, Cm1, Llo1, Lr8 | |
| P2 | Q3SB03: cysteine-rich venom protein pseudechetoxin-like | CAP domain; ShK domains; potassium channel blocker | M2, Cl2 | |
| P3 | Q98993: verrucotoxin subunit beta | SNTX/VTX toxin; hemolytic, cytolytic, hypotensive activities; calcium channel inhibitor | T1, Ch1, Cl1, Cm1, Llo1, Lr8, Rl1 | |
| P4 | Q75WF2: plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | M3, T2, Ch3, Cl3, Cm2, Llo2, Lr2, Rl2 | |
| T1 | Q91453: stonustoxin subunit beta | SNTX/VTX toxin; pore-forming; hemolytic, endema inducing activities | P3, Ch1, Cl1, Cm1, Rl1, Llo1 | |
| T2 | Q75WF2: plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | M3, P4, Ch3, Cl3, Cm2, Llo2, Lr2, Rl2 | |
| T3 | Q76CA2: echotoxin-2 | Echotoxin; anemone cytotox domain; pore-forming; hemolytic activity | Ch4, Cl4, Cm3, Lr3 | |
| T4 | Q66S13: natterin-4 | Natterin; Aerolysin domain; edema and nociception induction | Cm6, Lla6, Lr7 | |
| Ch1 | Q91453: stonustoxin subunit beta | SNTX/VTX toxin; pore-forming; hemolytic, endema inducing activities | P3, T1, Cl1, Lr1, Rl1 | |
| Ch2 | A0ZSK3: neoverrucotoxin subunit alpha | SNTX/VTX toxin; hemolytic activity | M1, P1, Cm1, Llo1, Lr8 | |
| Ch3 | Q75WF2: plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | M3, P4, T2, Cl3, Cm2, Llo2, Lr2, Rl2 | |
| Ch4 | Q76CA2: echotoxin-2 | Echotoxin; anemone cytotox domain; pore-forming; hemolytic activity | T3, Cm3, Lr3 | |
| Ch5 | B2DCR8: SE-cephalotoxin | Cephalotoxin; toxic function unknown | Cl5, Cm4, Lr4, Llo3, Rl3 | |
| Ch6 | P58912: toxin PsTX-60B | MACPF toxin domain; hemolytic activity | Cl6 | |
| Ch7 | Q76DT2: toxin AvTX-60A | MACPF toxin domain; hemolytic activity | Cl7 | |
| Cl1 | Q91453: stonustoxin subunit beta | SNTX/VTX toxin; pore-forming; hemolytic, endema inducing activities | P3, T1, Ch1, Lr1, Rl1 | |
| Cl2 | Q2XXQ3: cystein-rich venom protein ENH1 | CAP domain; ShK domains; potassium channel blocker | M2, P2 | |
| Cl3 | Q75WF2: plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | M3, P4, T2, Ch3, Cm2, Llo2, Lr2, Rl2 | |
| Cl4 | Q76CA2: echotoxin-2 | Echotoxin; anemone cytotox domain; pore-forming; hemolytic activity | T3, Ch4, Cm3, Lr3 | |
| Cl5 | B2DCR8: SE-cephalotoxin | Cephalotoxin; toxic function unknown | Ch5, Cm4, Llo3, Lr4, Rl3 | |
| Cl6 | P58912: toxin PsTX-60B | MACPF toxin domain; hemolytic activity | Ch6 | |
| Cl7 | Q76DT2: toxin AvTX-60A | MACPF toxin domain; hemolytic activity | Ch7 | |
| Cm1 | A0ZSK3: neoverrucotoxin subunit alpha | Neoverrucotoxin; hemolytic activity | P1, M1, Ch2, Llo1, Lr8 | |
| Cm2 | Q75WF2: plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | P4, T2, M3, Ch3, Cl3, Llo2, Lr2, Rl2 | |
| Cm3 | Q76CA2: echotoxin-2 | Echotoxin; pore-forming; hemolytic activity | T3, Ch4, Cl4, Lr3 | |
| Cm4 | B2DCR8: SE-cephalotoxin | Cephalotoxin; toxic function unknown | Ch5, Cl5, Llo3, Lr4, Rl3 | |
| Cm5 | P01527: cytotoxin A-III | Cytoxoxin A-III: pore-forming; kinase C, sodium, and calcium channel inhibitor | Ch5, Llo3, Lr4, Rl3 | |
| Cm6 | N/A: inferred as natterin-4 from reciprocal BLAST | Natterin; aerolysin domain; edema and nociception induction | T4, Lr7, Rl5 | |
| Llo1 | A0ZSK4: neoverrucotoxin subunit alpha | SNTX/VTX toxin; hemolytic activity | M1, P1, Ch2, Cm1, Lr8 | |
| Llo2 | Q75WF2: plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | M3, P4, T2, Ch3, Cl3, Cm2, Lr2, Rl2 | |
| Llo3 | B2DCR8: SE-cephalotoxin | Cephalotoxin: toxic function unknown | Ch5, Cl5, Cm4, Lr4, Rl3 | |
| Llo4 | P01527: cytotoxin A-III | Cytoxoxin A-III: pore-forming; kinase C, sodium, and calcium channel inhibitor | Cm5, Llo4, Lr5, Rl4 | |
| Lr1 | Q98989: stonustoxin | SNTX/VTX toxin; Pore-forming; Hemolytic, endema-inducing activities | P3, T1, Ch1, Cl1, Rl1 | |
| Lr2 | Q75WF2: Plancitoxin-1 | Plancitoxin; DNase II domain; Hepatotoxin | M3, P4, T2, Ch3, Cl3, Cm2, Llo2, Rl2 | |
| Lr3 | Q76CA2: Echotoxin-2 | Echotoxin; Pore-forming; Hemolytic activity | T3, Ch4, Cl4, Cm3 | |
| Lr4 | B2DCR8: SE-cephalotoxin | Cephalotoxin; toxic function unknown | Ch5, Cl5, Cm4, Llo3, Rl3 | |
| Lr5 | P01527: Cytotoxin A-III | Cytotoxin A-III; Pore-forming; Kinase C, sodium, and calcium channel inhibitor | Cl6, Llo4, Rl4 | |
| Rl1 | Q98989: stonustoxin | SNTX/VTX toxin; pore-forming; hemolytic, endema-inducing activities | T1, P3, Ch1, Cl1, Llo1 | |
| Rl2 | Q75WF2: plancitoxin-1 | Plancitoxin; DNase II domain; hepatotoxin | M3, P4, T2, Ch3, Cl3, Cm2, Llo2, Lr2 | |
| Rl3 | B2DCR8: SE-cephalotoxin | Cephalotoxin: toxic function unknown | Ch5, Cl5, Cm4, Llo3, Lr4 | |
| Rl4 | P01527: cytotoxin A-III | Cytoxoxin A-III: pore-forming; kinase C, sodium, and calcium channel inhibitor | Lr4, Cm5, Llo3 | |
| Rl5 | Q66S13: natterin-4 | Natterin; aerolysin domain; edema and nociception induction | T4, Cm6, Lr7 |